PARP1 and neoplasm: It was recently reported that small-molecule p97-complex inhibitors, including a metabolite of Disulfiram, prolonged PARP1 trapping (preventing DNA repair leading to cell death) and enhanced PARP inhibitor-induced cytotoxicity in homologous recombination-defective tumor cells and patient-derived tumor organoids (38, 39).